PKD1 and prostate carcinoma: SD-208 inhibited the growth of PC3 prostate cancer cells with an IC50 of 17μM, and its anti-proliferative activity was reversed by overexpression of PKD1 and PKD3, indicating inhibition of PKD accounts for the anti-proliferative effect of SD-208.